SCIENTISTS have developed a new drug that could protect against damage to brain cells which are ravaged by Alzheimer’s disease.
I’m now optimistic NitroMemantine will be effective as we advance to human trials, bringing new hope to both early and later-stage Alzheimer’s patients
Dr Stuart Lipton
The Latest Bing News on:
- Neuropathic Pain: Multiple Mechanisms at Multiple Siteson April 2, 2021 at 5:00 pm
Future Neurology. 2007;2(6):661-671. Future trends in pain-related ion-channel research are likely to involve deconstructions of native ion-channel compositions, distributions, interactions and ...
The Latest Google Headlines on:
The Latest Bing News on:
- Researchers from the University of California, Santa Barbara and the University of Cambridge, UK Receive 2021 Potamkin Prize for Alzheimer's Researchon April 15, 2021 at 12:36 pm
The 2021 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases has been awarded to Kenneth S. Kosik, MA, MD, University of California Neuroscience Research Institute, Santa Barbara, ...
- Hypoxia compromises the mitochondrial metabolism of Alzheimer’s disease microglia via HIF1on April 15, 2021 at 10:45 am
Microglia can help clear amyloid β plaques in the Alzheimer’s disease brain but may also become dysfunctional and can contribute to disease progression. March-Diaz et al. reveal that hypoxia, a ...
- Understanding Alzheimer's and Dementiaon April 15, 2021 at 9:33 am
Dr. Morgan Sauer with Baptist Health Systems joins Theba Lolley for a conversation about understanding terminology associated with Alzheimer's and Dementia.
- In surprising twist, some Alzheimer's plaques may be protective, not destructiveon April 15, 2021 at 8:00 am
One of the characteristic hallmarks of Alzheimer's disease (AD) is the buildup of amyloid-beta plaques in the brain. Most therapies designed to treat AD target these plaques, but they've largely ...
- Potential Blood Biomarker for TBI, and Mechanistic Link with Alzheimer’s Disease Identifiedon April 15, 2021 at 5:00 am
Previously unidentified neuroprotective effects of two NSAIDs might help to prevent traumatic brain injury patients from developing Alzheimer’s disease.
- Loss of Pleasure Linked to Early-Onset Dementia Not Alzheimer’s, New Study Findson April 15, 2021 at 5:00 am
A new study from scientists at the University of Sydney, Australia, shows early-onset dementia or frontotemporal dementia (FTD) is strongly associated with a loss of ability to experience pleasure ...
- Multimodal, label-free fluorescence and Raman imaging of amyloid deposits in snap-frozen Alzheimer’s disease human brain tissueon April 15, 2021 at 4:19 am
Lochocki et al. report detection of amyloid plaques by label-free fluorescence and Raman imaging in snap-frozen frontal cortex tissue from Alzheimer’s disease cases. They identify presence of ...
- Dementia and Alzheimer's Disease Treatment Market by Application & Type – Global Forecast 2028on April 15, 2021 at 3:06 am
Research Nester released a report titled "Dementia and Alzheimer's Disease Treatment Market: Global Demand Analysis ...
- Sen. Stabenow introduces new bill aimed at improving care for Alzheimer’s patientson April 14, 2021 at 2:57 pm
The bipartisan bill is expected to reduce medical complications for these patients by creating a new way to fund dementia care through Medicare.
- Research shows links between gum disease and Alzheimer'son April 14, 2021 at 11:49 am
New research adds to evidence linking gum disease with Alzheimer's disease. The mouth is home to both harmful bacteria that promote inflammation and healthy, protective bacteria, the study authors ...